National and Kapodistrian University of Athens
Η επίδραση της συνεχούς υποδόριας χορήγησης ροπιβακαΐνης δια και μετεγχειρητικά στο μετεγχειρητικό πόνο μετά από λαπαροσκοπική χολοκυστεκτομή
Abstract
dc:descriptionBackground: Wound infusion with local anesthetics has been used for postoperative pain relief with variable results. We hypothesized that perioperative continuous infusion of ropivacaine would affect the analgesic requirements and ameliorate postoperative acute, late and chronic pain. This randomized, controlled, double-blind clinical study examines the effect of subcutaneous ropivacaine infusion on acute and chronic pain and analgesic requirements after laparoscopic cholecystectomy. Methods: One hundred ten patients scheduled for laparoscopic cholecystectomy were randomized to receive either 0.75% ropivacaine (ropivacaine group) or normal saline (control group) continuous infusion installed immediately after induction of anesthesia and continued throughout the first 24 hours postoperatively. Anesthesia and intraopearative analgesia were standarized in all patients. After induction of anesthesia a multihole catheter 75 mm long was inserted by the surgeon subcutaneously and parallel to the right subcostal area and connected to an elastomeric pump containing 0.75 % ropivacaine or 0.9 % normal saline as indicated by the randomization table and delivering 2 ml of fluid per hour. Patients received either ropivacaine 0.75 %or 0.9 % saline during the first 24 hours postoperatively. For postoperative pain patients had free access to Lonarid® tablets containing 10 mg of codeine and 400 mg of paracetamol. Tramadol (converted to paracetamol) and paracetamol consumed in Post Anesthesia Care Unit (PACU), Lonarid® tablets consumed during the first 2, 4, 8, 24 and 48 hours and pain scores at rest and during cough for the same time points were recorded. Shoulder pain if present was also recorded. One and three months postoperatively patients were interviewed on phone for persisting postsurgical pain and for the analgesic tablets consumed at home. Results: Of the 136 patients assessed for eligibility 110 patients were randomized. The two groups did not differ postoperatively in pain at rest (p=0.079) or in analgesic consumption in PACU (p=0.149) and during the first 48 hours (p=0.42). The ropivacaine group reported less pain during cough (p=0.044) in PACU (p=0.017) and 4 hours after surgery (p=0.038). No difference was found in the incidence of patients who reported persisting pain or analgesic consumption one (p=0.563 and p=0.251 respectively) and three months (p=0.414 and p=0.495 respectively) postoperatively. Conclusion: Perioperative wound infusion with 0.75% ropivacaine decreased the immediate acute pain associated with cough after laparoscopic cholecystectomy but had no effect on pain at rest or analgesic consumption beyond the first four hours after surgery. The incidence of patients presented with chronic pain or requiring analgesics one and three months after surgery did not differ between the groups.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vassi, Aimilia
- Βάσση, Αιμιλία
Subjects
dc:subject × 14- Οξύς μετεγχειρητικός πόνος
- Ροπιβακαΐνη
- Χρόνιος πόνος
- Συνεχής έγχυση τοπικού αναισθητικού
- Λαπαροσκοπική χολοκυστεκτομή
- Acute postoperative pain
- Ropivacaine
- Chronic pain
- Continuous infusion of local anesthetic
- Laparoscopic cholecystectomy
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38671